Projects per year
Personal profile
Education
- 2013 美國加大洛杉磯分校 訪問學者
- 2011 國立成功大學臨床醫學研究所 博士
Experience
- 2018/08 ~ 迄今 成大生化所生物化學暨分子生物學研究所 兼任教師
- 2003/08 ~ 迄今 成大醫院一般內科 主治醫師
- 2013/08 ~ 2014/07 美國UCLA 進修
- 2001/08 ~ 2003/07 成大醫院內科部胸腔科 總醫師
- 1998/08 ~ 2001/07 成大醫院內科部 住院醫師
Research Interests
- 胸腔醫學
- 胸腔腫瘤學
- 支氣管內視鏡超音波
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Chien-Chung Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Finished
-
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
Lin, C. Y., Hu, C. H., Hsu, C. F., Tsai, J. S., Chen, C. W., Lin, C. Y., Chang, C. C., Yen, Y. T., Tseng, Y. L., Su, P. L. & Lin, C. C., 2023, (Accepted/In press) In: Thoracic Cancer.Research output: Contribution to journal › Article › peer-review
Open Access -
Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer
Perng, P. S., Hsu, H. P., Lee, P. H., Huang, C. C., Lin, C. C. & Lee, J. S., 2023 Jan, In: Asian Journal of Surgery. 46, 1, p. 269-276 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
Chu, C. Y., Lin, C. Y., Lin, C. C., Li, C. F., Wu, S. Y., Tsai, J. S., Yang, S. C., Chen, C. W., Lin, C. Y., Chang, C. C., Yen, Y. T., Tseng, Y. L., Su, P. L. & Su, W. C., 2023 Dec, In: Scientific reports. 13, 1, 3943.Research output: Contribution to journal › Article › peer-review
Open Access -
Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin
Lin, C. Y., Wei, S. H., Chen, Y. L., Lee, C. T., Wu, S. Y., Ho, C. L., Pavlick, D. C., Su, P. L. & Lin, C. C., 2022 Aug 11, In: Frontiers in Oncology. 12, 919123.Research output: Contribution to journal › Article › peer-review
Open Access -
Durable Response of Dabrafenib, Trametinib, and Capmatinib in an NSCLC Patient With Co-Existing BRAF-KIAA1549 Fusion and MET Amplification: A Case Report
Chou, Y. T., Lin, C. C., Lee, C. T., Pavlick, D. C. & Su, P. L., 2022 Mar 18, In: Frontiers in Oncology. 12, 838798.Research output: Contribution to journal › Article › peer-review
Open Access